Only 2,000 small drugmakers in India have good manufacturing practice certification from the World Health Organization.

India-UK FTA excludes patent term extensions and data exclusivity, safeguarding Indian generic drug industry interests.

Laurus Labs shares have seen a sudden surge, bringing cheer to investors. ImmunoACT, a related company, has turned profitable for the first time, which is a significant milestone. India’s pharma ...

In an exclusive interview with Business Today, D. Sridhar Babu, Minister for Information Technology, Industries and Commerce, ...

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat long-term conditions.

A panel discussion at the e4m Health & Wellness Marketing Conference explored how pharma storytelling is shifting from ...

In a written reply to the Lok Sabha, Anupriya Patel shared that government schemes promoted domestic manufacturing of medical ...

Panaji: The India-UK free trade agreement (FTA) will significantly benefit Goa’s pharmaceutical companies, tourism sector, ...

A strategic blueprint to build India’s consulting champions — through fairer procurement rules and structural support — to ...

India has the potential to turn that principle into practice by making the next generation of therapies not only practical but also accessible and affordable. If it succeeds, India won’t just lead the ...

YANGON: The Embassy of India in Myanmar, in collaboration with the India-Myanmar Chamber of Commerce and Industry (IMCCI), hosted the "PHARMA CONNECT 2025" event on the evening of July 25 at the Pan ...

The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India’s Pharma MedTech sector from cost- to ...